Peptides DB
Research-centric peptide and protocol reference hub

KPV vs SS-31

Updated July 27, 2026 · Reviewed by the PeptidesDB Editorial team

KPV: Research use — not FDA-approvedSS-31: Research use — not FDA-approved

A data-driven comparison of KPV and SS-31 (also searched as SS-31 vs KPV) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

KPV centers on inflammation, while SS-31 leans toward inflammation. On indexed research, SS-31 is ahead (KPV: 12 studies, Human evidence; SS-31: 19, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • KPV is strongest for inflammation; SS-31 for inflammation.
  • Evidence: KPV Human evidence (12 studies) vs SS-31 Human evidence (19).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

KPV: Healing 4.0, Muscle 0.0, Metabolic 0.0, Neuro 0.0, Sleep 0.0, Immune 5.0, Skin 0.0 — SS-31: Healing 3.0, Muscle 2.0, Metabolic 4.0, Neuro 3.0, Sleep 1.0, Immune 4.0, Skin 0.0Healing & recovery — 4.0 / 5 · KPVInflammation & immune — 5.0 / 5 · KPVHealing & recovery — 3.0 / 5 · SS-31Muscle & body comp — 2.0 / 5 · SS-31Metabolic & appetite — 4.0 / 5 · SS-31Neuro & mood — 3.0 / 5 · SS-31Sleep & circadian — 1.0 / 5 · SS-31Inflammation & immune — 4.0 / 5 · SS-31HealingMuscleMetabolicNeuroSleepImmuneSkin
KPVSS-31

At a glance

KPVHuman evidence

Anti-Inflammatory Tripeptide | Alpha-MSH Fragment

Strongest: InflammationStudies: 12Level: Emerging
SS-31Human evidence

Mitochondrial-Targeted Peptide | Cardiolipin Protector

Strongest: InflammationStudies: 19Level: Well Studied

KPV vs SS-31: side-by-side

MetricKPVSS-31
ClassImmuneLongevity
Regulatory statusResearch use onlyResearch use only
Evidence gradeHuman evidenceHuman evidence
Studies indexed1219
Research levelEmergingWell Studied
Strongest effectInflammation & immuneInflammation & immune
Healing & recovery4.03.0
Muscle & body comp0.02.0
Metabolic & appetite0.04.0
Neuro & mood0.03.0
Sleep & circadian0.01.0
Inflammation & immune5.04.0
Skin & aesthetics0.00.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyKPVSS-31
MechanismInteractions with immune cells, enhancing anti-inflammatory responsesTargets inner mitochondrial membrane to enhance function and reduce ROS
RouteSubcutaneous injection

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is KPV?

### KPV Summary KPV is a tripeptide composed of lysine, proline, and valine, which has garnered interest in research for its potential roles in modulating immune responses and promoting wound healing. Its implications in various therapeutic contexts, particularly in inflammatory conditions, are currently being explored.

Full KPV profile, mechanism & studies →

What is SS-31?

### Summary SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.

Full SS-31 profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingKPV4.0/5 effect signal
MuscleSS-312.0/5 effect signal
MetabolicSS-314.0/5 effect signal
NeuroSS-313.0/5 effect signal
SleepSS-311.0/5 effect signal
InflammationKPV5.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack KPV and SS-31?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

KPV vs SS-31: side effects

KPV

No community-reported effects logged yet.

SS-31

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

KPV has 12 approved studies indexed (Human evidence), and SS-31 has 19 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is KPV or SS-31 better?

It depends on your goal. KPV is strongest for inflammation; SS-31 for inflammation. SS-31 has more indexed studies (19). See the goal-by-goal breakdown above.

Is KPV or SS-31 better for weight loss?

SS-31 shows the stronger metabolic & appetite profile (4.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is KPV or SS-31 better for muscle?

SS-31 leads on the muscle & body-composition axis (2.0/5).

Which has more research, KPV or SS-31?

KPV has 12 approved studies indexed (Human evidence); SS-31 has 19 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack KPV and SS-31?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of KPV vs SS-31?

KPV: no community-reported effects logged yet. SS-31: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is KPV or SS-31 FDA-approved?

KPV is a research-use compound and is not FDA-approved. SS-31 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is SS-31 better than KPV?

For inflammation, SS-31 has the edge; for inflammation, KPV does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

KPV and SS-31 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 27, 2026.